NCT04700488View on ClinicalTrials.gov

Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 19, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
PDAC - Pancreatic Ductal Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

6D-MRI

Six-Dimensional Quantitative Dynamic Contrast Enhanced MRI

Trial Locations (1)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER